Browsing by Subject
Ara mostrant els elements 1-13 d 13
-
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma
(Oxford University Press, 2023-01) -
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
(American Society of Clinical Oncology, 2021-03-20) -
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy
(Oxford University Press, 2022-12) -
The Role of CT-Based Radiomics in Precise Imaging of Renal Cancer
(Sciaccess Publishers, 2021-07-06) -
Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease
(Frontiers Media, 2022-10-04)